Concepedia

J. Næsdal

JN

Statistics

Publications

7

Citations

541

H-Index

7

Active since

1990

Affiliations

AstraZeneca (Sweden)(Current)

Institute of Clinical Research

University of Michigan

Mayo Clinic

J. Næsdal is an author at AstraZeneca (Sweden) specializing in clinical pharmacology, pharmacology, and gastrointestinal pharmacotherapy.

Publications per year

1990–2011

7

Publications

7

Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors

James M. Scheiman, Neville D. Yeomans, Nicholas J. Talley et al. · The American Journal of Gastroenterology · 2006 · 301 citations

, , +15

Improvements with Esomeprazole in Patients with Upper Gastrointestinal Symptoms Taking Non-Steroidal Antiinflammatory Drugs, Including Selective COX-2 Inhibitors

C J Hawkey, Nicholas J. Talley, Neville D. Yeomans et al. · The American Journal of Gastroenterology · 2005 · 96 citations

, , +13

Intravenous omeprazole: effect of a loading dose on 24‐h intragastric pH

J. Andersen, M. Ström, J. Næsdal et al. · Alimentary Pharmacology & Therapeutics · 1990 · 45 citations

, , +13

The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk

Stephen D. Pratt, VINCENT THOMPSON, Eric P. Elkin et al. · American Journal of Cardiovascular Drugs · 2010 · 40 citations

, , +6

Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies

Christopher J. Hawkey, Nicholas J. Talley, James M. Scheiman et al. · Arthritis Research & Therapy · 2007 · 25 citations · Full text

, , +10

1–5 of 7